ICD-10-CM Billable Code

M31.3

Wegener's granulomatosis

Clinical Classification Guidelines

Inclusion Terms

  • Granulomatosis with polyangiitis
  • Necrotizing respiratory granulomatosis

Medical Intelligence & Overview

Wegener's granulomatosis, now more commonly known as granulomatosis with polyangiitis (GPA), is a rare autoimmune disorder that causes inflammation of the blood vessels (vasculitis). This inflammation can restrict blood flow to various organs, leading to tissue damage. The condition often affects the respiratory system and kidneys but can involve multiple organs. Recognizing its signs early can lead to more effective management and improve quality of life.

Causes & Symptoms

Clinical Causes: The exact cause of granulomatosis with polyangiitis is unknown, but it involves an abnormal immune response where the body's immune system attacks healthy blood vessels. Genetic factors may predispose certain individuals to the disease, especially those with a family history of autoimmune conditions. Environmental exposures, such as inhalation of certain particles or chemicals, might trigger the immune response in genetically susceptible individuals. Infections have also been studied as potential contributors, but no direct causative agent has been confirmed.

Key Symptoms: Persistent nasal congestion or sinus issues Nosebleeds or sores inside the nose Coughing, which may produce blood Shortness of breath or wheezing Chest pain Unexplained fatigue and weight loss Fever and night sweats Joint pain or swelling Skin rashes or ulcers Kidney problems such as blood in urine or decreased kidney function

Diagnostic & Treatment

Diagnosis Path: Diagnosing granulomatosis with polyangiitis involves a combination of medical history, physical examination, and various tests, including: - Blood tests to detect inflammation and specific antibodies (such as ANCA) - Urinalysis to assess kidney function - Imaging studies like chest X-rays or CT scans to evaluate lung involvement - Biopsy of affected tissues (nasal tissue, lung, kidney) to observe characteristic granulomas and vasculitis under a microscope - Additional tests to rule out other conditions with similar symptoms It is essential for healthcare providers to perform a comprehensive assessment to establish an accurate diagnosis.

Treatment Protocols: While there is no cure for granulomatosis with polyangiitis, treatment aims to control inflammation, suppress the immune response, and prevent organ damage. Common approaches include: - Immunosuppressive medications such as cyclophosphamide or methotrexate - Corticosteroids like prednisone to reduce inflammation quickly - Maintenance therapy with drugs like azathioprine or mycophenolate mofetil after remission - Regular monitoring to assess organ function and adjust treatment as necessary - In some cases, plasma exchange therapy may be used to remove harmful antibodies from the blood Treatment plans are tailored to individual needs and disease severity, requiring ongoing medical supervision.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M31.3 a billable ICD-10 code?
Yes, M31.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M31.3?
Clinical documentation must specify the nature of Wegener's granulomatosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

granulomatosis